384 related articles for article (PubMed ID: 17145603)
1. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Brugiatelli M; Bandini G; Barosi G; Lauria F; Liso V; Marchetti M; Mauro FR; Meloni G; Zinzani PL; Tura S; ; ;
Haematologica; 2006 Dec; 91(12):1662-73. PubMed ID: 17145603
[TBL] [Abstract][Full Text] [Related]
2. Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation.
Barosi G; Carella A; Lazzarino M; Marchetti M; Martelli M; Rambaldi A; Tarella C; Vitolo U; Zinzani PL; Tura S
Haematologica; 2005 Sep; 90(9):1236-57. PubMed ID: 16154848
[TBL] [Abstract][Full Text] [Related]
3. Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Barosi G; Carella A; Lazzarino M; Marchetti M; Martelli M; Rambaldi A; Tarella C; Vitolo U; Zinzani PL; Tura S; ; ;
Haematologica; 2006 Jan; 91(1):96-103. PubMed ID: 16434377
[TBL] [Abstract][Full Text] [Related]
4. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
5. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
Alessandrino EP; Amadori S; Barosi G; Cazzola M; Grossi A; Liberato LN; Locatelli F; Marchetti M; Morra E; Rebulla P; Visani G; Tura S;
Haematologica; 2002 Dec; 87(12):1286-306. PubMed ID: 12495903
[TBL] [Abstract][Full Text] [Related]
6. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Barbui T; Barosi G; Grossi A; Gugliotta L; Liberato LN; Marchetti M; Mazzucconi MG; Rodeghiero F; Tura S
Haematologica; 2004 Feb; 89(2):215-32. PubMed ID: 15003898
[TBL] [Abstract][Full Text] [Related]
7. Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.
Brusamolino E; Bacigalupo A; Barosi G; Biti G; Gobbi PG; Levis A; Marchetti M; Santoro A; Zinzani PL; Tura S
Haematologica; 2009 Apr; 94(4):550-65. PubMed ID: 19278966
[TBL] [Abstract][Full Text] [Related]
8. Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).
Barosi G; Boccadoro M; Cavo M; Corradini P; Marchetti M; Massaia M; Merlini G; Tosi P; Tura S; ; ;
Haematologica; 2004 Jun; 89(6):717-41. PubMed ID: 15194540
[TBL] [Abstract][Full Text] [Related]
9. Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
Morra E; Barosi G; Bosi A; Ferrara F; Locatelli F; Marchetti M; Martinelli G; Mecucci C; Vignetti M; Tura S
Haematologica; 2009 Jan; 94(1):102-12. PubMed ID: 19001282
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
[TBL] [Abstract][Full Text] [Related]
11. Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
Imberti D; Di Nisio M; Donati MB; Falanga A; Ghirarduzzi A; Guarneri D; Piovella F; Santoro RC; Baldini E; Zampogna S;
Thromb Res; 2009 Nov; 124(5):e32-40. PubMed ID: 19744700
[TBL] [Abstract][Full Text] [Related]
12. Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma).
Tarella C; Arcaini L; Baldini L; Barosi G; Billio A; Marchetti M; Rambaldi A; Vitolo U; Zinzani PL; Tura S
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):75-85. PubMed ID: 25108679
[TBL] [Abstract][Full Text] [Related]
13. SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.
Mauro FR; Bandini G; Barosi G; Billio A; Brugiatelli M; Cuneo A; Lauria F; Liso V; Marchetti M; Meloni G; Montillo M; Zinzani P; Tura S; ; ;
Leuk Res; 2012 Apr; 36(4):459-66. PubMed ID: 21885123
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in the management of chronic lymphocytic leukemia.
Robak T
Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
[TBL] [Abstract][Full Text] [Related]
15. [Chronic lymphocytic leukemia].
Maurer C; Hallek M
Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
[TBL] [Abstract][Full Text] [Related]
16. The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy.
Giné E; Moreno C; Esteve J; Montserrat E
Best Pract Res Clin Haematol; 2007 Sep; 20(3):529-43. PubMed ID: 17707838
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
Eichhorst BF; Busch R; Obwandner T; Kuhn-Hallek I; Herschbach P; Hallek M;
J Clin Oncol; 2007 May; 25(13):1722-31. PubMed ID: 17389338
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia: from palliative therapy to curative intent.
Meloni G; Mauro FR; Proia A; Mandelli F
Haematologica; 1998 Jul; 83(7):660-2. PubMed ID: 9718872
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplantation for chronic lymphocytic leukemia.
Dreger P; Brand R; Michallet M
Semin Hematol; 2007 Oct; 44(4):246-51. PubMed ID: 17961723
[TBL] [Abstract][Full Text] [Related]
20. The clinical and epidemiological burden of chronic lymphocytic leukaemia.
Redaelli A; Laskin BL; Stephens JM; Botteman MF; Pashos CL
Eur J Cancer Care (Engl); 2004 Jul; 13(3):279-87. PubMed ID: 15196232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
